PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 147 filers reported holding PLIANT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.7%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,132,867 | $38,647,550 | 34.92% |
| TRV GP III, LLC | 339,160 | $6,145,579 | 33.70% |
| CHI Advisors LLC | 3,117,017 | $56,480,348 | 17.14% |
| GREAT POINT PARTNERS LLC | 1,550,184 | $28,089,334 | 5.50% |
| Deep Track Capital, LP | 4,050,000 | $73,386,000 | 3.40% |
| Casdin Capital, LLC | 1,700,000 | $30,804,000 | 2.69% |
| First Light Asset Management, LLC | 1,810,176 | $32,800,389 | 2.57% |
| Fernwood Investment Management, LLC | 380,727 | $6,898,773 | 2.45% |
| Redmile Group, LLC | 2,678,099 | $48,527,154 | 1.86% |
| Bond & Devick Financial Network, Inc. | 100,160 | $1,814,899 | 1.13% |
| VR Adviser, LLC | 288,949 | $5,235,756 | 0.84% |
| Artia Global Partners LP | 100,000 | $1,812,000 | 0.62% |
| RA Capital Management | 1,762,000 | $31,927,440 | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 107,267 | $1,943,678 | 0.60% |
| Avidity Partners Management LP | 916,600 | $16,608,792 | 0.58% |
| DIFESA CAPITAL MANAGEMENT, LP | 11,000 | $199,320 | 0.52% |
| Granahan Investment Management | 810,357 | $14,683,669 | 0.45% |
| Laurion Capital Management LP | 3,158,570 | $57,233,288 | 0.32% |
| HighVista Strategies LLC | 34,035 | $616,714 | 0.28% |
| HARBOURVEST PARTNERS LLC | 49,434 | $895,744 | 0.25% |
External links
This page lists PLIANT THERAPEUTICS INC's shareholders in Q2 2023. To view PLIANT THERAPEUTICS INC's shareholder history, click here.